Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
leukemia
Biotech
Kura's leukemia drug works best when tacked onto existing combo
New data from Kura Oncology’s phase 1b trial show that its oral leukemia treatment performed best on top of a standard-of-care combo regimen.
Max Bayer
Jan 30, 2024 11:15am
FDA lets Curis resume enrollment for phase 1/2 leukemia study
Aug 31, 2022 7:50am
FDA lifts clinical hold on Curis' phase 1/2 lymphoma trial
Aug 18, 2022 11:23am
Acadia culls painkiller rival to Vertex and cancer drug
Aug 9, 2022 10:21am
X4 joins handful of biotechs sending staff out the door
Jul 21, 2022 10:55am
FDA expands oversight over TG's stalled U2 cancer combo therapy
Jan 28, 2022 8:15am